Industry:Biotech & Pharma
Cornerstone Therapeutics Inc
Cornerstone Therapeutics Inc (CRTX:US)
was acquired by 97612Z:IM
Cornerstone Therapeutics, Inc. is a biopharmaceutical company that discovers, develops, and commercializes therapeutic products. The Company develops products that are designed to regulate the body's inflammatory response associated with asthma and critical care diseases, and products for the respiratory market.